Strategy

Photo
09.03.2021 • NewsStrategy

CO2-Neutral Chemical Industry by 2050

The European Chemical Industry has set out on an ambitious path to become carbon neutral. Germany, as one of the major chemical manufacturing nations, has committed to achieve this goal by 2050. But companies need to translate this industry vision into their specific context.

Photo
08.03.2021 • NewsStrategy

The European Chemical Industry’s New Normal

A trusted adviser to major companies with a chemical industry background, and a Global Expert with the World Economic Forum, Paul Hodges, chairman of New Normal Consulting, reflects on the issues the post-Brexit chemical industry must tackle.

Photo
22.02.2021 • NewsStrategy

Steady in the Long Term Despite the Crisis

For the report "Value Creation in Chemicals 2020: Bouncing Back from a Year of Adversity", Boston Consulting Group (BCG) analyzed the development of the global chemicals market in the Covid-19 crisis in 2020 and in the years 2015 to 2019 using key figures. The result shows: The current crisis is forcing companies to increase their resilience. The entire value chain, exposure to the end industry, and technical, commercial and digital capabilities must be put to the test in order to respond more effectively to changes in the markets in the future.

Photo
04.02.2021 • NewsStrategy

BASF again Named World’s Most Valuable Chemicals Brand

A coalescing of factors has led to arrested growth across the chemicals sector this year, with the brand value of the top 25 most valuable chemicals brands contracting by 8% on average, according to the latest report by Brand Finance, an independent brand valuation consultancy.

Photo
04.12.2020 • NewsStrategy

Connected Work

We are in an increasingly volatile global climate, from health and economic crises, to trade wars on multiple fronts, to political unease, to name just a few.

Photo
04.12.2020 • NewsStrategy

Proactively Shaping the Transformation Path

The goal of a CO2-neutral chemical industry in 2050 is comparable with a 30 year marathon – but at sprint speed. So we have to find the best route to this common goal. This is the conclusion of a conference organized by the Association for Chemistry and Economics (VCW), a sub-sector of the German Chemical Society (GDCh).

Photo
03.12.2020 • NewsStrategy

Trade, Innovation and Investment

US chemistry remains in demand around the world despite ongoing trade tensions and Covid-19. In 2019, the US chemical industry was one of the world’s largest exporters, at $136 billion. The industry has a large and growing trade surplus, reaching more than $35 billion in 2019.

Photo
01.12.2020 • TopicsStrategy

Changes in Trade with the United Kingdom

On Dec. 31, 2020, the UK will leave the EU single market and customs union. Regardless of any agreement reached with the EU, the end of the Brexit transition period will affect citizens, businesses, as well as travel between the UK and EU. Therefore, businesses need to prepare themselves for the upcoming changes.

Photo
20.10.2020 • TopicsStrategy

The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs

The coronavirus crisis caused by the Covid-19 pandemic has uncovered problems that have been smoldering beneath the surface of the pharmaceutical industry — including CMOs/CDMOs and CROs — and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

Photo
17.10.2020 • TopicsStrategy

Expert Interview: Andrew Henderson, Sterling Pharma Solutions

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

Photo
17.10.2020 • TopicsStrategy

Expert Interview: Mark Quick, Recipharm

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

418 more articles

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.